BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11306463)

  • 1. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4.
    Wallace M; Ball KL
    Mol Cell Biol; 2004 Jun; 24(12):5606-19. PubMed ID: 15169919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression.
    Sterner JM; Tao Y; Kennett SB; Kim HG; Horowitz JM
    Cell Growth Differ; 1996 Jan; 7(1):53-64. PubMed ID: 8788033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterizations reveal different properties between CDK4/cyclin D1 and CDK2/cyclin A.
    Kim DM; Yang K; Yang BS
    Exp Mol Med; 2003 Oct; 35(5):421-30. PubMed ID: 14646596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
    Wang J; Walsh K
    Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the substrate specificity of cdk4 kinase-cyclin D1 complex.
    Grafstrom RH; Pan W; Hoess RH
    Carcinogenesis; 1999 Feb; 20(2):193-8. PubMed ID: 10069453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
    Nath N; Wang S; Betts V; Knudsen E; Chellappan S
    Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for phosphorylation sites in the retinoblastoma protein of D-type cyclin-dependent kinases, Cdk4 and Cdk6, in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Semba K; Kitagawa M; Taya Y; Hirai H
    J Biochem; 2005 Mar; 137(3):381-6. PubMed ID: 15809340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the minimal portion of the retinoblastoma protein that serves as an efficient substrate for cdk4 kinase/cyclin D1 complex.
    Pan W; Sun T; Hoess R; Grafstrom R
    Carcinogenesis; 1998 May; 19(5):765-9. PubMed ID: 9635861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin-dependent kinase 4.
    Leng X; Noble M; Adams PD; Qin J; Harper JW
    Mol Cell Biol; 2002 Apr; 22(7):2242-54. PubMed ID: 11884610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation.
    Zhang JM; Zhao X; Wei Q; Paterson BM
    EMBO J; 1999 Dec; 18(24):6983-93. PubMed ID: 10601020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4.
    Zhang JM; Wei Q; Zhao X; Paterson BM
    EMBO J; 1999 Feb; 18(4):926-33. PubMed ID: 10022835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
    Serrano M; Hannon GJ; Beach D
    Nature; 1993 Dec; 366(6456):704-7. PubMed ID: 8259215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of DNA polymerase alpha activity by cdk2-phosphorylated Rb protein.
    Takemura M; Yamamoto T; Kitagawa M; Taya Y; Akiyama T; Asahara H; Linn S; Suzuki S; Tamai K; Yoshida S
    Biochem Biophys Res Commun; 2001 Apr; 282(4):984-90. PubMed ID: 11352649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
    Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
    Féliers D; Frank MA; Riley DJ
    Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity.
    Siegert JL; Rushton JJ; Sellers WR; Kaelin WG; Robbins PD
    Oncogene; 2000 Nov; 19(50):5703-11. PubMed ID: 11126356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Stypmann J; Schmid C; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):117-24. PubMed ID: 20123249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.